Evogene

21 May 2026, Israel: Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small molecules for the pharmaceutical and

02 April 2026, Israel: Casterra Ag Ltd. (“Casterra”), a developer of high-yield castor seed varieties and integrated castor farming solutions, and a

22 November 2025, Israel: Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative design of small

12 November 2025, Israel: Casterra Ag Ltd. (“Casterra”), an Israeli developer of high-yield castor seed varieties and integrated castor farming solutions —

21 August 2025, Israel: Evogene Ltd. (Nasdaq, TASE: EVGN), a leading computational biology and chemistry company aiming to revolutionize the development of

13 August 2025, Israel: Evogene Ltd. (Nasdaq, TASE: EVGN), a leading computational biology and chemistry company, today announced a scientific collaboration with the

09 July 2025, Israel: Evogene Ltd. (Nasdaq, TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive biology to

12 June 2025, Israel: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company focused on revolutionizing life-science product discovery and

22 May 2025, Israel: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based

10 May 2025, Rehovot: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and